SLBT ▲ +5.8% - SL Science Holding Limited $SLBT - SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform 27-AUG-2026 08:00 AM ET